Clinical Trial Update: Multi-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer

View source ↗

Summary

Clinical trial investigating a multi-omic approach to high-dose-rate brachytherapy for localized prostate cancer; current status is recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Localized Prostate Cancer

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: Localized Prostate Carcinoma | Status: RECRUITING